News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Intratumoral, pembrolizumab and mRNA-2752 for high-risk Ductal Carcinoma In Situ
Jan 21, 2025, 05:12

Intratumoral, pembrolizumab and mRNA-2752 for high-risk Ductal Carcinoma In Situ

Kristina Jankovic, Medical Oncology Resident at University Clinical Center Nis, shared a post on X:

“Intratumoral, pembrolizumab and mRNA-2752 for high-risk DCIS : Phase 1 nonrandomized trial

80% response rate
no major systemic toxicities
complete tumor resolution in some possible surgery reduction
Ongoing studies needed.”

Intratumoral Injection of mRNA-2752 and Pembrolizumab for High-Risk Ductal Carcinoma In SituA Phase 1 Nonrandomized Clinical Trial

Authors: Kirithiga Ramalingam, Rachel Woody, Alexa Glencer

Intratumoral, pembrolizumab and mRNA-2752 for high-risk Ductal Carcinoma In Situ

Alexa Glencer cancer Kirithiga Ramalingam Kristina Jankovic OncoDaily Oncology Rachel Woody
Special Coverage
Science
Mar 3, 2025, 15:58
Esranur Aydın: Metastatic IDH2-mutant cholangiocarcinoma treated with venetoclax and decitabine
Science
Mar 3, 2025, 15:56
Selpercatinib in RET Fusion-Positive NSCLC by Oliver Gautschi et al.
Blog
Mar 3, 2025, 15:54
Jihan Azar: Childhood Cancer Inequalities in the WHO Eastern Mediterranean Region
Insight
Mar 3, 2025, 15:53
Arthur Sun Myint: Beacon of hope for patients with rectal cancer wishing to avoid major surgery and a stoma
Blog
Mar 3, 2025, 15:53
Toufic Kachaamy: Aasma Shaukat on how AI might accelerate precision medicine initiatives for CRC prevention
Blog
Mar 3, 2025, 15:52
Magdalena Skipper: An assault of science and scientists anywhere is an assault on science and scientists everywhere
Science
Mar 3, 2025, 15:51
Patrick Hwu: Are B cells important to eliminate cancers?
Blog
Mar 3, 2025, 15:50
Wafaa Rashed: Honored to feature Dr. Mary Relling in PAPERI Bright Minds Series episode
Blog
Mar 3, 2025, 15:49
Wafik El-Deiry: Discussing Legorreta Cancer Center's programmatic leadership
Blog
Mar 3, 2025, 15:48
Registration is open for the ASCO-Endorsed CPOEM Foundation Webinar
Insight
Mar 3, 2025, 15:47
Jill Feldman: ASCO's updated living guidelines for treating stage IV NSCLC
Blog
Mar 3, 2025, 15:47
Uta Dirksen: We have officially opened the first pediatric oncology ward in Eritrea